Literature DB >> 4479320

Treatment of ocular hypertension with oral beta-adrenergic blocking agents.

M Pandolfi, A Ohrström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4479320     DOI: 10.1111/j.1755-3768.1974.tb01757.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


× No keyword cloud information.
  9 in total

1.  Letter: Beta-blockers in the treatment of chronic simple glaucoma.

Authors:  C I Phillips
Journal:  Br Med J       Date:  1976-03-06

2.  Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.

Authors:  M J Elliot; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

3.  Beta-blockers in the treatment of chronic simple glaucoma.

Authors:  R A Hitchings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-10

4.  Comparison of ocular hypotensive effects of acetazolamide and atenolol.

Authors:  M J Macdonald; S M Gore; P M Cullen; C I Phillips
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

5.  Effect of topical atenolol on intraocular pressure.

Authors:  K Wettrell; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

6.  Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol.

Authors:  M Nakashima; T Uematsu; Y Takiguchi; H Hashimoto; I Watanabe; S Morioka; T Hibino
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Intraocular pressure reduction during treatment with pilocarpine and systemic propranolol. A comparative double-masked study.

Authors:  K Wettrell
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-09-30

8.  Timolol in operated closed-angle glaucoma.

Authors:  C I Phillips
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

9.  Dose response of oral timolol combined with adrenaline.

Authors:  A Ohrström
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.